Embed Size (px)
Citation preview
rp. Crapa 3aropa
LJ,EHOBO nPE,D,Jl0}!{EHV1E
s npou,eAypa 3a Bb3JlaraHe Ha o6w,ecrseHa nopb4Ka c npeAMer
",LJ,OCTABKA HA JlEKAPCTBEHV1 nPO,lJ,YKTV13A HY}!{,lJ,V1TE HA LJ,CMn-CTAPA 3ArOPA nPE3 2017 r."
/
Or: 11TbproscKa f11-1ra Hau,1-1oHa11eH Anre4eH LJ,e HTbp" AfJ.
c aApec: rp.Cocj>lo1R, 6y11. J .M.,lJ,l-1Ml-1Tpos" N2 1
re/1.: 02 960 37 80, cj>aKc: 02 962 41 27, e-mail : [email protected]
EV1K/6YJ1CTAT:030276307
Perl-1crpaU,l-1R no 3A,lJ,C: BG030276307
CMeTKa IBAN: BG23 UNCR 7630 1001 CLNP HC
BIC KOA Ha 6aHKara UNCRBGSF
YBA}!{AEMA rocnO}!{O ,lJ,V1PEKTOP,
Bbs spb3Ka c y4acr1-1ero Hl-1 s ropenoco4eHara
npeAMeT ",LJ,OCTABKA HA J1EKAPCTBEHV1 nPO,LJ,YKTV1 3A HY>I<,LJ,V1TE HA LJ,CMn-CTAPA 3
\ ... . ... <,,'· ... · ' 'i.t - -~
........ ·-~..:.-::_ -:~: .::.::_.~: .. ....:. ..
/-
.:.. I ·- I i
Aspartate 10 m l
9 A07BA01 Medicinal powde
Charcoal 20g 6p.
r
10 v Humul in , Eli sol.inj. 32,17 38,60 J R Lilly / .....
suspensi Nederl
~~~ on for and
injection B.V." ~~0 A10AB01 Insulin Human 3001U on .x 5
100
3&.
IU/ml- 3
ml x5
cartr idge
s
11 A11DA01 Thiamine sol.inj. 40mg on.x 10
12 Calcium sol.inj. 8,94 mg/ml A12AA03 on.x 5
gluconate, -10 ml
13 Magnesium sol.inj. 403,8 mg/ I A12CC02
1
on.x 10 sulphate 10 ml
14 Magnesium sol.inj. 201,9 mg/ on .x10 A12CC02
sulphate 10 ml
-~ 15 Heparin
sol.inj . 5000 IU/ml on .x10 B01AB01
- 5 ml
16 B01AD02 Alteplase Fl. 50 mg 6p.
17 70/50/ Pe3op6V1pyeMa 10 , crepV11lHa,
B02BC XeMOCTaTV14Ha MM 6p.
ro6a or
>+<enaTV1H CTaHp,a
preH
18 70/10/
Pe3op6!11pyeMa 1/
I I , crepVIIlHa, MM B02BC XeMOCTaTV14Ha 6p. I
ro6a or cneu,V1a I I ~ I
>+<ell arV1 H -
~~··i . .. I ~~~···r- ., /,.' I 1 neH ,\;.'~ J •l A J II 2 .·/I ,; ~ ~;.· .
r'~-(:$ [:f,!l ·~'; \ ' . -- i
' ~- - ! ·"; //
\ / . '-(· ', \
' '- --.
19 Pe3op61.1pyeMa 80/30M
1 crep1-111Ha 1 M
B02BC xeMOCTaTW·l Ha 6p ..
ro6a or aHaneH
>Ke/laTI-1H
20 10/10/ Pe3op61-1pyeMa
10 1 crepl-111Ha 1
B02BC XeMOCTaTW·lHa MM 6p ..
ro6a or
>Ke!laTI-1H p,eHTa/1
eH
21 Pe3op61.1pyeMa 1rp.ny
1 crepl-111Ha 1 p,pa
B02BC XeMOCTaTW·l Ha 6p.
ro6a or
>KellaTI-1H
22 Pe3op61-1pyeMa 200/70
1 crepl-111Ha 1 /015
B02BC X€MOCTaTI-1YHa MM 6p.
ro6a or
>KenaTI-1H TbHbK
23 30/30/
Pe3op61.1pyeMa 10
1 crepl-111Ha 1
B02BC X€MOCTaTI-1YHa MM 6p.
f""b6a OT /dial/ >Kenarl-1H
24 fleYe6
Ha
f""b6a fleYe6Ha ro6al
o6s1-1ra o6s1-1ra c
c YOBeWKI-1
B02BC cPI-16pl-1HOreH 1-1
YOBeW 6p.
KVI YOBeWKVI
i TpOM61.1H cj>1.16pl-1
HOreH
515Mr
Ha
KB.CM 111
40B€W
Kit!
rpoM6
lt!H 21U
Ha
KB.CM-
9,5/4,8
CM
25 fle4e6
Ha
ro6a
o6s111ra
c
40B€W
Kit!
Jle4e6Ha ro6a, <t>~t~6plt1
o6s~t~ra c HoreH
40B€WK1t1 5,5Mr B02BC
<t>~t~6pi1HOreH 11 6p.
Ha 40B€WKit1 KB.CM 1t1 rpoM6~t~H 4osew
Kit!
rpoM6
lt1H 21U
Ha
KB .CM-
4,8/4,8
CM
26 Jle4e6
Ha
ro6a
Jle4e6Ha ro6a, o6s11ra
o6s~t~ra c c
4osew 40B€WK1t1
B02BC <PI16pi1HOreH 1t1
Kit! 6p.
40B€WKit1 <PI16plt1
TpOM611H HoreH
5,5Mr
L Ha ~---//1·· - -·- . r KB.CM 11
~·, ... ,. / l! ~ ,,- --m
40 sew ~. ,... l ll •. • •• /. ·, • I .- .~1/ll / . <:::1 • . • 1 '. l -- ' ' : ' ' ' ,i(L>. j \c Jjj// ~ ·::.:: u...r . -
\-~-- / t ;::':::: / . . "-").// ·,, -~· .~' '/. .. .. /_/ -..._---
27 BOSAA07
28
BOSBB01
29
BOSBB01
30
BOSBB01
31
BOSBB01
Potassium
chloride
Calcium
chloride/
Potassium
chloride/
Sodium
chloride
Calcium
chloride/
Potassium
chloride/
Sodium
chloride
Calcium
chloride/
Potassium
chloride/
Sodium
chloride
Sodium
Chloride,
Sodium Lactate
solution,
Potassium
Chloride,
Calcium
Chloride
dihydrate
Kl-1
rpoM6
1-lH 2 IU
Ha
KB.CM-
3,0/2,5
CM
sol.inj.
6aHKa
6aHKa
6aHKa
150 mg/ml
-10 ml
0,33 g/ 0,3
g/ 8,6 g/1-
250 ml
0,33 g/ 0,3
on.x 5
6p.
g/ 8,6 g/1- on.x10
500 ml
0,33 g/ 0,3
g/ 8,6 g/1 - 6p.
1000 ml
6aHKa Sodium
Chloride 6
g/1, Sodium
Lactate
solution 50
%6,34 g/1
Potassium
Chloride
0,4 g/1,
Calcium
Chloride
dihydrate
0,27 g/1-
500 ml
on.x 1
32 6aHKa Sodium
Chloride 6
Sodium g/1, Sod ium
Lactate Chloride,
solution 50 Sodium Lactate
solution, % 6,34 g/1
Potassium BOSBB01 Potassium
Chloride on.x 1
Chloride,
Calcium 0,4 g/1,
Calci-um Chloride
Chloride dihydrate
dihydrate
0,27 g/1-
1000 ml
33 Sodium 6aHKa BOSBB03
0,9%-500
chloride ml on .x 20
34 Sodium 6aHKa BOSBB03
0,9%-
chloride 1000 ml on.x10
35 6aHKa 10%-500 BOSBC01 Mannitol
ml on .x 10
36 BOSCX01 Glucose
sol.inj . 25%-10
ml on.xS
37 BOSCX01 Glucose
sol.inj. 40%-10
ml on.x 5
38 BOSXA03
Sodium 6aHKa 9 g/1- 250
chloride ml on.x1
39 Sodium sol. inj.
BOSDBOO hydrogen 8,4 %/
carbonate 20m I
on .x 5
40 C01AAOS Digoxin
sol.inj . 0,5 mg/ 2
ml on.x 10
I 41 C01BB01 Lidocaine sol.inj. 10 mg/ml-
10 ml on .x 5
42 ~~:---~;
C01BB01 Lidocaine sol.inj. 20 mg/ml - ~,,:.,\C<i .. i( )J;J I I I
10 ml on .x , ~7(~~~ 1 1
,' ,.' <~
i: ; {;JfJ!.lv . . . I • . II \ . I (:) I
43 COlBBOl Lidocaine spray
44 COlBDOl Amiodarone
sol.inj .
45 Dopamine sol.inj. C01CA04
Hydrochloride
46 Dobutamine
sol.inj. C01CA07
47 Epinephrine
sol.inj. C01CA24
48 Glyceril sol. inf. C01DA02
trinitrate
49 Glyceril spray C01DA02
trinitrate
50 lsosorbide spray C01DA08
dinitrate
51 C02AC01 Clonidine sol.inj.
52 v Furoser 11 Ya~Ka sol.inj . . solution ct>apMa \ 'I' for BV1COKO I
~ ' - injection Ka4eCT ~: ~ -· ··. C03CA01 Furosemide • . .. 1 lOmg/ml BeHV1Te
- 2ml x neKapc
10 rsa 11 A/J,
53 Metoprolol sol.inj. C07AB02
tartrate
54 tab I. C07AB03 Atenolol
55 Nordipin 11 Ya~Ka tab I.
tablet ct>apMa
~ 10mgx BV1COKO
(\~ . \ C08CA01 Amlodipine 30 Ka4eCT
BeHV1Te
neKapc
TBa 11 A/J.
10%-38 g 6p.
50 mg/ml-
3 ml on.x 6
40 mg/ml -
5 ml on.x 10
5 mg/ml-
50ml on .x 1
1 mg/ml-1
ml on.x 10
1 mg/ml -
50 ml on .x 1
0,4 6p.
mg/dose
1,25 6p.
mg/dose
0,15 mg/ml on.x 10
10 mg/ml-on.x 10
2ml
1 mg/ml - 5 6p.
ml
50 mgx onaK.X 30
306p.
I 10 mgx onaK.x30
306p. I I
3,75 4,50
-·
11,02 13,22
''·
I f ""' I
'
· r If ) ~ ''
d:- ~ # JJ;jr ) ( ' ! ()~ ~~ L ..:- · 'P '-I
\ :· ~ ··~ ' /
\ -·. t .. { ' \.\ ·- ·. . .. ~/ \ ,,
.. "::
56 C08DA01 Verapamil
sol.inj. 2,5 mg/ml-
2 ml on.x 10
57 oinmen 0,133 Salicylic
t g/100 g, D03AX acid.Benzoic
0,5 mg/100 6p.
acid.Malic acid g, 4,5 mg
58 Salicylic cut.sol.
D03AX acid. Benzoic 80ml 6p.
acid.Malic acid
59 Diphenhydrami oinmen
D04AA32 ne t 20 mg/g 6p.
hydrochloride
61 Methylergomtr sol.inj. 0,2 mg/ml-
G02AB01 ine hydrogen 6p. 1 ml
maleate
62 H01BB02 Oxytocin sol.inj. 5 IU/1 ml 6p.
63 Dexamethason sol.inj. H02AB02 8 mg on .x 10
e
64 Dexamethason sol.inj. H02AB02 4mg on .x 10
I e
65 Methylprednis sol.inj. H02AB04 15,78 mg on.x 10
alone
66 Methylprednis sol.inj. H02AB04
alone 40 mg on.x 10
67 Methylprednis sol.inj. H02AB04
alone 125 mg on.x 5
68 Methylprednis sol.inj. H02AB04
alone 250 mg on.x 5 I
I I I
69 Methylprednis sol.inj . H02AB04 500 mg 6p.
alone
70 powde
H04AA01 Glucagon r and 1 mg on.x 1 :7-J ~\
solvent ~ ':;;) '/', \\;~·. 't 1."/(
for j t&' I ~>/I I n--:--.. .. ~ . _j_ . -- , I
rr -. I Lf;fJIU/~ ' 1$! .... , ;
I \._-:, I _, I ,c; \ I
\~ '. "·~ \. ·. ~ -\,.Y ' " ··"'
solutio
n for
inj.
71 J06AA02
Tetanus
antitoxin
sol.inj. 15001U 6p.
72 Viper venom sol.inj. 100 6p. J06AA03
antiserum AE/amp.
73 sol.inj. tetanus
J07AM01 Tetanus toxoid toxoid> 40 on.x 10
IU
74 Suxamethoniu sol.inj. 20 mg/ml-6p. M03AB01
5 ml m
75 Suxamethoniu sol.inj. 10 mg/m l -6p. M03AB01
5ml m
76 M03AC04 Atracurium sol.inj. 25 mg 6p.
77 pow de
r and
solvent
M03AC06 Pipecuronium
for 4mg 6p. bromide
solutio
n for
inj.
78 Fentanyl
sol.inj. 0,1 mg/ 2 N01AH01
ml on.x 10
79 sol.inj. 500 mg/ 10 N01AX03 Ketamine on.x 5
ml
80 emuls. 10 mg/ml-N01AX10 Propofol
for inj . 50 ml 6p.
81 Lidocaine/ urethra N01BBS2
Chlohexidine I gel 12,5 g 6p.
82 Lidocaine/ urethra N01BB52 8,5 g 6p.
Chlohexidine I gel
83 N02AA01 Morphine sol.inj. 10 mg on.x 10
·~~ 84 N02AA01 Morphine sol.inj. 20 mg on .x 10 L!l~·~\\ ~~l~ u ,r~ I , . -
(I ' . ( . ~-
' . / -::: !
" I ."\ /
85 Naloxone N02AASS
Hydrochloride
86 Metamizole N02BB02
sodium
87 N03AA02 Phenobarbital
88 Chlorpromazin NOSAA01
e
89 Haloperidol NOSAD01
90 NOSBA01 Diazepam
91 Midazolam NOSCD08
92 Midazolam NOSCD08
93 V03AB25 Flumazenil
---94 Buto- ,Yai:!Ka
Asma ¢apMa
Pressuris BltlCOKO
·~~-:l ed Ka4ecr
, I inhalatio BeHltlTe (
~~1 R03AC02 Salbutamol n, fleKapc
suspensi rsa" AfJ. on 0,1
mg/dose
-200
doses x 1
95 R03DAOS Aminophylline
96 R06AD02 Promethazine
197 Pitofenone and A03DA02
analgesics
98 B02BX1 Etamsylat
sol.inj . 0,4 mg/ml
sol.inj. 500 mg/ml
-2 ml
sol.inj. 200 mg
sol.inj. 50 mg 2Mfl
sol.inj. 5 mg/ml-1
ml
sol.inj. 10 mg -2
ml
sol.inj. 5 mg/ml- 3
ml
sol.inj. 1 mg/ml- 5
ml
sol.inj. 0,5 mg/ 5
ml
lnh.sus
p.
0,1
mg/dose-
200 doses
sol.inj. 24 mg/ml-
10 ml
sol.inj. 25 mg/ml-
1 ml
I .. S01.inj .
2ml
sol.inj. 250mg/2ml
on.x 10
on .x 10
on.x 10
on.x 10
6p.
on.x 10
6p.
6p.
6p.
j----·----
3,29 3,95 J
on.x 1
on.x 5
6p.
on.x 10 -~
~~ ~/ ' )
r • \
on.x 1o_gv·_y,~~8f~xJ ~- / I ,,
( t~\ } (I /~A -~ I I• \
99
100
101
N02BE01
N02BA01
BOSCX01
Paracetamol
supp.
Acidum
acetylsalicycum
Sodium
chloride and
glucosae
supp.x
106p
Tab I.
6aHKa
80 mg x 10 onaK.x 10
SOOmg x 20 onaK.x 20
SOOm l on.x 10
~10-2-t------+--------+-S-o-d-iu-m--+-, LJ-a--:i:1-:-K-a-+-so--:!-.in_j_. -+-----+----+-::-3--=,8--=3---l-4-,-::-60----1 ~r·:
BOSXA03
103 BOSAA07
104 R06AC03
105 C01BC03
I 106 NOSCM11
107 C01DA02
108 D03AA
109 D08AX08
110 D08AX01
111 D08AA01
112 D08AG03
Sodium
chloride
HAES steril-6%
Chloropyramin
e
Propafenone
Natrii
bromidum
Glyceryli
trinitrat
Retinol
palmitad
Etanol- 95%
Bo,LJ,opo,LJ,eH
nepOKCV1,ll,
Ethacridine
0,1%
Tinctura Jodi
5%
chloride- cpapMa
Tchaikap BV1COKO
harm a
Solution
for
Ka4eCT
BeHV1Te
fleKapc
injection rsa" A[J,
9 mg/m l
-10 ml x 20
0,9%-10m l on.x 20
6aHKa SOOml on .x 10
sol.inj. 2m I on.x 10
sol.inj . 35mg/m l-6p.
sol. inj.
Tab I.
oinmen
t
sol.
sol.
Sol.
Sol.
10ml
100mg/ml-
5ml on.x 10
0,5 mg x 40 onaK.x 40
1000ml
30%
1000ml
1000ml
1000ml
6p.
6p.
6p.
6p.
6p.
' 0 ., (' .. .J
113
114
115
117
118
. 119
120
121
122
123
124
127
128
D08AG02 Povidone -jod sol 100m I 6p.
D08AG02 Povidone -jod sol 1000ml 6p.
oinmen 10% 40r 6p. D08AG02 Povidone -jod
t
N02AB02 Pethidine sol.inj. 50mg/ml-
2m I on.x 10
Silver cream 6p. D06BA01 1%50g
sulfadiazin
D08AX08 Etanol70% Sol. 1000ml 6p.
BOAOPOAeH Sol. D08AX01 3% 100ml 6p.
nepOKCVIA
6aHKa B05CX01 Glucose 5% 500ml on.x 10
B05CX01 Glucose 6aHKa 10% SOOml on.x 10
Sodium B05XA03
chloride
sol.inj. 0,9%-5ml on.x 10
A06AA01 Liquid paraffin 80g 6p.
C01BB01 Lidokaine sol.inj. 20mg/ml-
2m! on.x 10
sol. 5mg/ml-Ventoline
20m I 6p.
I
npeAflaraHaTa U,eHa Tpfi6Ba Aa 6bAe 3a BCAKa HOMeHK!laTypa nOOTAe!lHO, Aa 6bAe OKOHYaTellHa -
U,eHa 3a eAvtHvtU,a MflpKa, nOC04eHa B TeXHvt4eCKaTa cneu,vt¢vtKaU,vtfl 3a CbOTBeTHaTa HOMeHK!larypa V1
Aa 6bAe npeAcraseHa s a6co!lfOTHa cyMa s 11esa, AO sropvt 3HaK c!leA Aecervt4Hara 3aneraA. 3a
V1Me vt ¢aMvtllvtfl ,ll,vtaHa 3a!l03HaA
